Skip to content
Research use only — not for human consumptionBatch documentation on requestThird-party tested purityDiscreet EU delivery21+ onlyMade in EuropeResearch use only — not for human consumptionBatch documentation on requestThird-party tested purityDiscreet EU delivery21+ onlyMade in Europe

RUO · 21+ Tik tyrimų naudojimui (RUO). Visi šioje svetainėje parduodami produktai skirti išimtinai laboratoriniams tyrimams. Jie nėra vaistai, maisto papildai ar preparatai, skirti vartoti žmonėms ar gyvūnams, ir nėra skirti diagnozuoti, gydyti ar užkirsti kelio jokioms ligoms. Naudodamiesi svetaine patvirtinate, kad jums 21+, ir kad perkate tik teisėtiems laboratoriniams tyrimams. Visa tyrimų naudojimo taisyklė

norecipe
RAPOFIL-200 (Modafinil Tablets USP)Research use only

RAPOFIL-200 (Modafinil Tablets USP)

Active ingredient: Modafinil 200 mg

Known names: Modafinil, Provigil (generic equivalent), Wakefulness-Promoting Agent.

200,00 €incl. VAT
In stockRUO
1

Discreet EU shipping. Certificate of analysis available on request. Not for human or animal consumption.

Forma
Tabletės

RAPOFIL-200 contains 200 mg of Modafinil, a prescription wakefulness-promoting medication used in the treatment of excessive daytime sleepiness associated with specific sleep disorders. It is commonly prescribed for conditions such as narcolepsy, obstructive sleep apnea (OSA), and shift work sleep disorder (SWSD).

Modafinil helps improve wakefulness, alertness, concentration, and mental performance in individuals experiencing excessive daytime sleepiness. Unlike traditional stimulants, it is designed to promote wakefulness while generally producing a lower risk of overstimulation.

It is important to note that RAPOFIL-200 does not cure underlying sleep disorders and should be used as part of a treatment plan recommended by a qualified healthcare professional. It is not intended as a substitute for adequate sleep or for treating ordinary fatigue in healthy individuals.

Research indications

  • RAPOFIL-200 may be prescribed for the management of
  • Excessive daytime sleepiness associated with narcolepsy
  • Residual sleepiness in patients with obstructive sleep apnea (alongside appropriate treatment)
  • Excessive sleepiness related to shift work sleep disorder

Usage guidelines

  • Use RAPOFIL-200 exactly as prescribed by your healthcare provider.
  • Typical dosing recommendations include
  • Narcolepsy & Obstructive Sleep Apnea: 200 mg once daily, usually in the morning.
  • Shift Work Sleep Disorder: 200 mg approximately one hour before the start of the work shift.
  • The dosage may vary depending on the patient’s medical condition and individual response to treatment.

Package content

  • 1 Package contains
  • Strip of 10 tablets
  • 200 mg Modafinil USP per tablet

Storage

  • Store below 30°C.
  • Keep in a dry place.
  • Protect from moisture and direct sunlight.
  • Keep out of reach of children.

Susiję junginiai

Rodyti visus